NEXI - NexImmune, Inc. Debt to Book Capitalization Ratio

Strict air transport and cold chain logistics ensure the reliability of NexImmune, Inc. (NEXI) tests. Debt-to-book capitalization for the company on the GURU.Markets temporary trajectory exhibits sideways movement, where the value 0.00 describes the current level of financial autonomy. Despite macro resilience and grant support, the business remains stagnant, requiring an R&D portfolio update to refresh its development strategy.

NEXI NexImmune, Inc.: Debt to Book Capitalization Ratio in the range 07/04/2022 - 08/04/2024

Summary analytical data breakdowns for NexImmune Inc (NEXI)

- price and consensus price forecast:

Stock Price NexImmune, Inc.|NEXI - Consensus Target

- market capitalization data:

Market Value NexImmune Corporation|NEXI - Total Enterprise Value

- book capitalization data:

Net Assets per Single Share NexImmune|NEXI - Company Book Value|Market Value to Book Value Ratio neximmune.com|NEXI - Company Assets

- debt and liquidity data:

Total Debt to Capital NexImmune, Inc.|NEXI - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio NexImmune Corp|NEXI - Company Cumulative Debt|Debt to Book Value NexImmune Corporation

Analysis of all company metrics:NEXI, NexImmune, Inc.

Finished products of NexImmune Corporation

NexImmune, Inc. (NEXI) is developing bioethical cancer immunotherapy with a focus on environmental safety and the energy efficiency of its laboratories. An analysis of the company's balance sheet financial leverage allows for an assessment of the ratio of total liabilities to its equity. This indicator measures the degree of the business's dependence on borrowed funds within its financing structure. An increase in this ratio signals rising credit risks and potential pressure on the share price. Investors utilize this metric to monitor the company's long-term sustainability.

Competitors of NexImmune, Inc.